CYChuansheng Yang

Chuansheng Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chuansheng Yang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Ruiwen Lei

    Department of Head-Neck and Breast Surgery, Yuebei People’s Hospital of Shantou University, Shaoguan, China

    2 shared publications
  • Wanming Wu

    Department of Head-Neck and Breast Surgery, Yuebei People’s Hospital of Shantou University, Shaoguan, China

    2 shared publications
  • Bingliang Cai

    Department of Breast, Thyroid and Head-Neck Surgery, Yuebei People’s Hospital, Shantou University Medical College, Shaoguan, China

    1 shared publication
  • Chaoling Yao

    Department of Head-Neck and Breast Surgery, Yuebei People’s Hospital of Shantou University, Shaoguan, China

    1 shared publication
  • Jiasheng Liu

    Department of Urology, Yuebei People’s Hospital, Shantou University Medical College, Shaoguan, China

    1 shared publication
  • Jinhao Li

    Department of Breast, Thyroid and Head-Neck Surgery, Yuebei People’s Hospital, Shantou University Medical College, Shaoguan, China

    1 shared publication

Latest Publications

  • Open Access

    Association of estimated glucose disposal rate with all-cause and breast cancer-specific mortality in US breast cancer survivors: a population-based study

    by Jinhao Li, Jiasheng Liu, Bingliang Cai, Chuansheng Yang

    Background: Insulin resistance (IR) is increasingly linked with poor cancer prognosis, but its impact on mortality among breast cancer patients—particularly regarding different causes of death—remains incompletely understood. The estimated glucose disposal rate (eGDR) is a surrogate index of insulin sensitivity. This study intended to investigate the links of eGDR with all-cause mortality (ACM) and breast cancer-specific mortality (BCSM) in US breast cancer survivors. Methods: Data were sourced from the 2007–2016 National Health and Nutrition Examination Survey(NHANES). A cross-sectional design was used to assess the link between eGDR and breast cancer prevalence, while a cohort design was adopted for mortality follow-up. Additionally, weighted logistic regression was leveraged to estimate the link between eGDR and breast cancer prevalence. Cox models were employed to evaluate the relationship between eGDR and ACM. Restricted cubic splines were utilized to model nonlinear links, and competing risk models were adopted to analyze BCSM. Results: Among 323 women with breast cancer, 73 deaths occurred during follow-up (median 6.2 years). After multiple confounders were controlled, a binary analysis using optimal cutoff values confirmed that higher eGDR was independently linked with lower ACM risk (HR: 0.40; 95% CI: 0.18–0.89; P = 0.025). This association was nonlinear, and the protective effect remained across multiple subgroups. In competing risk analysis, a potential association was observed between higher eGDR and lower BCSM risk (HR: 0.13; 95% CI: 0.02–0.99; P = 0.048), with no marked association observed for cardiovascular mortality. Conclusion: In US breast cancer survivors, higher eGDR was independently linked with lower ACM risk. This association may be partly driven by a reduction in BCSM, but this specific finding requires validation in larger studies due to considerable statistical uncertainty.


  • Open Access

    STC2 suppresses triple-negative breast cancer migration and invasion by inhibition on EMT and promotion on cell apoptosis

    by Ruiwen Lei, Chaoling Yao, Renfeng Huang, Wanming Wu, Linyang Ou, Chuansheng Yang

    To investigate the effects of higher cellular stanniocalcin 2 (STC2) on suppressing the migration and invasion but promoting the apoptosis of triple-negative breast cancer (TNBC). STC2 in TNBC and the para-carcinoma tissues were analyzed by immunohistochemistry (IHC), while the mRNA level was measured by qPCR. Over-expressing or silencing STC2 was established in MDA-MB-231 cells. Epithelial mesenchymal transition (EMT) related proteins, cell migration, invasion, proliferation and apoptosis were detected. MDA-MB-231 with over-expressing or silencing STC2 were injected into nude mice to formatting tumors, and then EMT related proteins were measured by IHC. Lower STC2 expressed in TNBC tissues than in the para-carcinoma tissues. Silencing STC2 promoted EMT of TNBC cell MDA-MB-231, as well as cell migration, invasion and proliferation, but suppressed MDA-MB-231 apoptosis, while over-expressing STC2 had the opposite results, which might be related to PKC/PI3K/AKT/mTOR pathway. STC2 was the protective gene in TNBC, by suppressing migration and invasion to inhibit MDA-MB-231 cell EMT but promote cell apoptosis, in order to suppress TNBC progression.


  • Open Access

    Development of a model for predicting mortality of breast cancer admitted to Intensive Care Unit

    by Renfeng Huang, Wanming Wu, Yan Guo, Linyang Ou, Xumeng Gong, Chuansheng Yang, Ruiwen Lei

    Background: There is still not a mortality prediction model built for breast cancer admitted to intensive care unit (ICU). Objectives: We aimed to build a prognostic model with comprehensive data achieved from eICU database. Methods: Outcome was defined as all-cause in-hospital mortality. Least absolute shrinkage and selection operator (LASSO) was conducted to select important variables which were then taken into logistic regression to build the model. Bootstrap method was then conducted for internal validation. Results: 448 patients were included in this study and 79 (17.6%) died in hospital. Only 5 items were included in the model and the area under the curve (AUC) was 0.844 (95% confidence interval [CI]: 0.804-0.884). Calibration curve and Brier score (0.111, 95% CI: 0.090-0.127) showed good calibration of the model. After internal validation, corrected AUC and Brier score were 0.834 and 0.116. Decision curve analysis (DCA) also showed effective clinical use of the model. The model can be easily assessed on website of https://breastcancer123.shinyapps.io/BreastCancerICU/. Conclusions: The model derived in this study can provide an accurate prognosis for breast cancer admitted to ICU easily, which can help better clinical management. Keywords: Breast neoplasms; intensive care unit; prognosis.